Open AccessLooking to the future of depression: instant diagnosis and medication-free treatment
Author(s) -
Daniel Månsson
Publication year - 2019
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.2144/fsoa-2019-0087
Subject(s) - depression (economics) , psychiatry , clinical neuroscience , mental health , simple (philosophy) , medicine , psychology , philosophy , epistemology , neurology , economics , macroeconomics
Daniel Mansson is a clinical psychologist, cofounder and CEO of Flow. As a clinical psychologist at Sarpsborg DPS, a psychiatric clinic in Norway, Daniel performed extensive investigations and treatments for patients with conditions including depression and attention deficit hyperactivity disorder. In 2012, Daniel met Erik Rehn, where they both worked in the research department of computational biology at KTH Royal Institute of Technology, Stockholm. In January 2016, with combined backgrounds in clinical psychology, computer networks, computational neuroscience and electrical engineering, they launched Flow. The mission was simple: to find new ways to treat mental health issues with the help of science and technology. Based in Malmo, Sweden, Daniel is the driving force behind Flow and spearheads the research, innovation and business development.